Text-only version of this email
Quince Therapeutics
April 1, 2024A Form 10-K has been filed with the United States Securities and Exchange Commission.
View this filing →
Or click here to view all filings.
Show allNew Form 10-K for Quince Therapeutics
Cortexyme sent this email to their subscribers on April 1, 2024.
| ||||||||
| ||||||||